搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Malus domestica Peptidyl-prolyl cis-trans isomerase Pin1 (PIN1) CSB-YP822020MPS
CSB-EP822020MPS
CSB-BP822020MPS
CSB-MP822020MPS
CSB-EP822020MPS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana 3-epi-6-deoxocathasterone 23-monooxygenase (CYP90D1), partial CSB-YP822021DOA
CSB-EP822021DOA
CSB-BP822021DOA
CSB-MP822021DOA
CSB-EP822021DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable methyltransferase PMT21 (ERD3), partial CSB-YP822022DOA
CSB-EP822022DOA
CSB-BP822022DOA
CSB-MP822022DOA
CSB-EP822022DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Zinc finger CCCH domain-containing protein 10 (Os01g0738400, LOC_Os01g53650) CSB-YP822023OFG
CSB-EP822023OFG
CSB-BP822023OFG
CSB-MP822023OFG
CSB-EP822023OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ananas comosus Profilin CSB-YP822024BYU
CSB-EP822024BYU
CSB-BP822024BYU
CSB-MP822024BYU
CSB-EP822024BYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein translation factor SUI1 homolog 2 (At1g54290) CSB-YP822025DOA
CSB-EP822025DOA
CSB-BP822025DOA
CSB-MP822025DOA
CSB-EP822025DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana F-box/kelch-repeat protein At3g06570 (At3g06570) CSB-YP822026DOA
CSB-EP822026DOA
CSB-BP822026DOA
CSB-MP822026DOA
CSB-EP822026DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana MLO-like protein 3 (MLO3), partial CSB-YP822027DOA1
CSB-EP822027DOA1
CSB-BP822027DOA1
CSB-MP822027DOA1
CSB-EP822027DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Syntaxin-52 (SYP52), partial CSB-YP822028DOA
CSB-EP822028DOA
CSB-BP822028DOA
CSB-MP822028DOA
CSB-EP822028DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Homeobox protein knotted-1-like 3 (HOS66) CSB-YP822029OFG
CSB-EP822029OFG
CSB-BP822029OFG
CSB-MP822029OFG
CSB-EP822029OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tamias quadrimaculatus Cytochrome b (MT-CYB), partial CSB-YP822030TEAE
CSB-EP822030TEAE
CSB-BP822030TEAE
CSB-MP822030TEAE
CSB-EP822030TEAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcebus ravelobensis NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP822031MIAG1
CSB-EP822031MIAG1
CSB-BP822031MIAG1
CSB-MP822031MIAG1
CSB-EP822031MIAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Episoriculus fumidus Cytochrome b (MT-CYB), partial CSB-YP822032EDAR
CSB-EP822032EDAR
CSB-BP822032EDAR
CSB-MP822032EDAR
CSB-EP822032EDAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Percopsis transmontana Cytochrome b (mt-cyb), partial CSB-YP822033PKAN
CSB-EP822033PKAN
CSB-BP822033PKAN
CSB-MP822033PKAN
CSB-EP822033PKAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microtus oaxacensis Cytochrome b (MT-CYB), partial CSB-YP822034MIAH
CSB-EP822034MIAH
CSB-BP822034MIAH
CSB-MP822034MIAH
CSB-EP822034MIAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Varanus baritji NADH-ubiquinone oxidoreductase chain 2 (MT-ND2), partial CSB-YP822035VBAI
CSB-EP822035VBAI
CSB-BP822035VBAI
CSB-MP822035VBAI
CSB-EP822035VBAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ctenomys latro Cytochrome b (MT-CYB), partial CSB-YP822036CKAM
CSB-EP822036CKAM
CSB-BP822036CKAM
CSB-MP822036CKAM
CSB-EP822036CKAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eulemur coronatus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP822037ECAH1
CSB-EP822037ECAH1
CSB-BP822037ECAH1
CSB-MP822037ECAH1
CSB-EP822037ECAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tamias merriami Cytochrome b (MT-CYB), partial CSB-YP822038TLC
CSB-EP822038TLC
CSB-BP822038TLC
CSB-MP822038TLC
CSB-EP822038TLC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ptenochirus jagori Cytochrome b (MT-CYB), partial CSB-YP822039PKAO
CSB-EP822039PKAO
CSB-BP822039PKAO
CSB-MP822039PKAO
CSB-EP822039PKAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>